Market Place
Sourcing Support
Scenic Biotech Names Roland W. Bürli as Chief Scientific Officer
09 Sep 2025 //
GLOBENEWSWIRE
Scenic Biotech Reveals Mitochondrial, Cardiac Disease Drug
03 Sep 2025 //
GLOBENEWSWIRE
Scenic Enters License and Research Agreement with Alnylam
26 Aug 2025 //
GLOBENEWSWIRE
Scenic Biotech Announces Nature Publication on Drug Target PLA2G1
07 May 2025 //
GLOBENEWSWIRE
Scenic Biotech Appoints Industry Veteran Ben Machielse to Board of Directors
11 Jul 2024 //
BUSINESSWIRE
Scenic Biotech Enters Research Collaboration with Bristol Myers Squibb
30 Apr 2024 //
BUSINESSWIRE
Scenic Biotech Announces Positive Preclinical Data for QPCTL Inhibitor SC-2882
09 Dec 2023 //
BUSINESSWIRE
Scenic Enters Agreement with National Institutes of Health for Genetic Treatment
01 Feb 2023 //
BUSINESSWIRE
Scenic Biotech Strengthens Team with the Addition of Kristof Van Emelen
19 Jan 2023 //
BUSINESSWIRE
Scenic Biotech Appoints Jens Würthner as Chief Medical Officer
24 Oct 2022 //
BUSINESSWIRE
Scenic Biotech and the Barth Syndrome Foundation Announce Partnership
30 Mar 2022 //
PRNEWSWIRE
$31M to progress pipeline of genetic modifiers in cancer and rare diseases
10 Mar 2022 //
PHARMAFILE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.